News + Filings Transactions
|
KLEMA CATHY
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
04/30/2019 | Allergan plc | AGN | Payment of Exercise | Ordinary Shares, par value $0.0001 | 953 | $147.00 | $140.1k | | 04/30/2019 |
03/11/2019 | Allergan plc | AGN | Other (acquisition) | Ordinary Shares, par value $0.0001 | 410 | $0.00 | $0 | | 03/11/2019 |
05/02/2018 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 2k | $151.07 | $299.9k | | 05/02/2018 |
05/04/2017 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 1.2k | $245.25 | $299.9k | | 05/04/2017 |
08/08/2016 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 201 | $248.31 | $49.9k | | 08/08/2016 |
05/05/2016 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 1.2k | $210.34 | $249.9k | | 05/05/2016 |
06/05/2015 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 826 | $302.30 | $249.7k | | 06/05/2015 |
06/05/2015 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 826 | $302.30 | $249.7k | | 06/04/2015 |
06/04/2015 | Allergan plc | AGN | Payment of Exercise | Ordinary Shares, par value $0.0001 | 549 | $303.38 | $166.6k | | 06/04/2015 |
06/04/2015 | Allergan plc | AGN | Payment of Exercise | Ordinary Shares, par value $0.0001 | 549 | $303.38 | $166.6k | | 06/05/2015 |
05/09/2014 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 1.1k | $197.05 | $225k | | 05/09/2014 |
10/01/2013 | Allergan plc | AGN | Grant | Ordinary Shares | 19.6k | $0.00 | $0 | | 10/01/2013 |
08/12/2013 | Actavis, Inc. | ACT | Sale | Common Stock, par value $0.0033 | 1.7k | $133.03 | $221.8k | | 08/06/2013 |
08/09/2013 | Actavis, Inc. | ACT | Gift | Common Stock, par value $0.0033 | 3.3k | $0.00 | $0 | | 08/06/2013 |
08/06/2013 | Actavis, Inc. | ACT | Gift | Common Stock, par value $0.0033 | 5k | $0.00 | $0 | | 08/06/2013 |
01/04/2010 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC | PPDI | Grant | Common Stock | 2.8k | $0.00 | $0 | | 01/04/2010 |
|